Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
Enzymatic debridement is the use of a topical enzyme product to break down dead tissue in a wound. In the United States the most-studied product of this kind is a prescription collagenase ointment, which means it is a regulated drug supplied by label, not a dressing, tray or device. This page describes products and general use; it is not medical advice.
Who uses it: clinic staff, supply buyers and students who need to know what the product class is, what its label says and how strong the evidence behind it is.
What is enzymatic debridement?
Debridement means removing dead or damaged tissue from a wound. The enzymatic form relies on a proteolytic enzyme applied to the wound surface. The enzyme most studied is collagenase from the bacterium Clostridium histolyticum. The FDA-approved label for Collagenase Santyl Ointment states one indication: debriding chronic dermal ulcers and severely burned areas (DailyMed, label revised 5/2019, checked 2026-11-04).
Because it is a drug, it sits on a different procurement and storage path from the physical items in a clinic’s wound kit. For those items, see the wound care clinic supply checklist, which mentions enzymatic debridement only in passing, and the guides on dermal curettes and wound irrigation supplies.
How collagenase debriding ointments are built and labelled
The labelled product is a sterile ointment: collagenase in a white petrolatum base. The label gives the strength as 250 collagenase units per gram and states that sterility is guaranteed until the tube is opened.
What the label says
| Label item | What the FDA label states |
|---|---|
| Indication | Debriding chronic dermal ulcers and severely burned areas |
| Form and strength | Topical ointment, 250 collagenase units per gram in white petrolatum USP |
| Package data | Tube; a 30 g tube is listed in the package data |
| Storage | Do not store above 25°C (77°F) |
| Contraindication | Local or systemic hypersensitivity to collagenase |
| Incompatibility | Heavy metal ions such as mercury and silver, used in some antiseptics, can reduce enzyme activity |
| Children | Safety and effectiveness in pediatric patients have not been established |
Source: DailyMed official label, Collagenase Santyl Ointment (Smith & Nephew), set ID 6b6fbfc6-98fa-46aa-88ef-ab00fbb08ffd, checked 2026-11-04. Always read the current label for the product in hand; this table reflects the 2019 revision.
What the evidence shows
A systematic review and meta-analysis (Patry and Blanchette, International Wound Journal, 2017) found results that support collagenase for enzymatic debridement in pressure ulcers and diabetic foot ulcers, and with topical antibiotics in burns when enzymatic debridement is judged necessary in selected cases. The same review reports limits that matter to a buyer:
- Included studies had a high risk of bias, with numerous and different outcomes.
- Most of the included articles were funded by industry.
- The pooled risk ratio for an adverse event related to collagenase versus the alternative treatment, across 10 studies, was 1.79.
So “enzymatic” should not be read as “proven better”.
Safe use and handling basics
- It is a drug product with its own FDA label, not a general wound-care consumable.
- The label’s storage limit is not above 25°C (77°F).
- The label lists local or systemic hypersensitivity to collagenase as a contraindication.
- Note the label’s warning about mercury and silver: antiseptics or dressings containing heavy metal ions can reduce enzyme activity. For a different dressing class, see the hydrocolloid wound care guide.
Common mistakes
- Filing it with devices and kits. It is a drug product with its own label, storage and prescribing requirements.
- Assuming every “debridement” item on a checklist is interchangeable. The checklist guide lists a tray for sharp and enzymatic debridement together, but the enzyme product itself is separate.
- Reading the evidence as stronger than it is: the main review rates its included studies at high risk of bias.
Frequently asked questions
Is enzymatic debridement a device or a drug?
The product documented here, Collagenase Santyl Ointment, is a drug with its own FDA label, not a device, dressing or kit.
What is the enzyme in this product?
Collagenase derived from fermentation by Clostridium histolyticum, at 250 collagenase units per gram in white petrolatum USP.
What pack sizes does the label list?
A 30 g tube and a 90 g tube.
Is the evidence strong?
Not clearly. The 2017 systematic review reports a high risk of bias in the included studies, mostly industry funding, and a pooled adverse-event risk ratio of 1.79 (10 studies).
Sources
- DailyMed (U.S. National Library of Medicine): Collagenase Santyl Ointment label, checked 2026-11-04.
- Patry J, Blanchette V. Enzymatic debridement with collagenase in wounds and ulcers: a systematic review and meta-analysis. Int Wound J 2017;14(6):1055-1065. PubMed Central, checked 2026-11-04.







